EUVIMEDEUVIMED entdecken
Crossref

Evaluating plasma phoenixin-14, galanin, galanin-like peptide, and spexin levels in polycystic ovary syndrome

Meltem Yardim, Huseyin Fatih Gul, Ulku Ayse Turker Aras

Irish Journal of Medical Science (1971 -) · 2025

DOI: 10.1007/s11845-025-04074-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Irish Journal of Medical Science (1971 -), 2025. Verfasst von Meltem Yardim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Yerkoy State Hospital, SelcukNamik Kemal Cd. No:2, 66900, Yerkoy, Yozgat, Türkiye. meltem_yardim@hotmail.com. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Galanin, Peptide Hormones, Galanin-Like Peptide. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Impaired central neuropeptide production is implicated in polycystic ovary syndrome (PCOS). AIM: This study aimed to determine whether plasma phoenixin-14, galanin (GAL), galanin-like peptide (GALP), and spexin levels in women with PCOS were altered compared to those in non-PCOS controls. METHODS: Sixty participants, including 30 patients diagnosed with PCOS and 30 healthy controls, were enrolled in this study. Phoenixin-14, GAL, GALP, and spexin levels were measured in plasma samples. RESULTS: Although plasma phoenixin-14 levels in the PCOS group were significantly higher than those in the control group, spexin and GAL levels were significantly lower. No significant intergroup differences were observed in plasma GALP levels (p = 0.442). To distinguish PCOS from healthy controls, the area under the receiver operating characteristic (ROC) curve (AUC) of phoenixin-14 was 0.798, that of spexin was 0.757, and that of GAL was 0.702 (p < 0.001, p < 0.001, and p = 0.003, respectively). The AUC of the combined diagnostic value of the three peptides for PCOS was 0.910 (95%CI: 0.808-0.968) (p < 0.001), indicating a good diagnostic value. CONCLUSIONS: Plasma phoenixin-14, spexin, and GAL levels differed between patients with PCOS and controls. When combined, the three peptides exhibited better predictive performance than the individual peptides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeGalaninPeptide HormonesGalanin-Like PeptideHumansFemaleAdultCase-Control StudiesYoung AdultROC CurveBiomarkers

Stichwörter der Autor:innen

GalaninGalanin-like peptideNeuropeptidePCOSPhoenixin-14Spexin

Substanzen

GalaninPeptide HormonesGalanin-Like PeptideSPX protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Medical Biochemistry, Yerkoy State Hospital, SelcukNamik Kemal Cd. No:2, 66900, Yerkoy, Yozgat, Türkiye. meltem_yardim@hotmail.com.
  • Department of Medical Biochemistry, Faculty of Medicine, Kafkas University, Kars, Türkiye.
  • Department of Obstetrics and Gynecology, Faculty of Medicine, Kafkas University, Kars, Türkiye.

Zitieren

APA

Yardim, M., Gul, H. F., & Aras, U. A. T. (2025). Evaluating plasma phoenixin-14, galanin, galanin-like peptide, and spexin levels in polycystic ovary syndrome. Irish Journal of Medical Science (1971 -). https://doi.org/10.1007/s11845-025-04074-4

Vancouver

Yardim M, Gul HF, Aras UAT. Evaluating plasma phoenixin-14, galanin, galanin-like peptide, and spexin levels in polycystic ovary syndrome. Irish Journal of Medical Science (1971 -). 2025. doi:10.1007/s11845-025-04074-4

BibTeX
@article{Yardim2025,
  author = {Yardim, Meltem and Gul, Huseyin Fatih and Aras, Ulku Ayse Turker},
  title = {Evaluating plasma phoenixin-14, galanin, galanin-like peptide, and spexin levels in polycystic ovary syndrome},
  journal = {Irish Journal of Medical Science (1971 -)},
  year = {2025},
  doi = {10.1007/s11845-025-04074-4}
}
Kostenlos starten →